English
简体中文
Total: £ 56.28
Published Date: 2026-03-14 | Pages: 134 | Tables: 130 | Medical Care
The global In Vitro Drug Release Testing market was valued at US$ 73.96 million in 2025 and is anticipated to reach US$ 187 million by 2032, at a CAGR of 14.3% from 2026 to 2032.
In Vitro Drug Release Testing is an experimental method used to evaluate the rate and extent of drug release from a pharmaceutical formulation over a specified period of time. This test is commonly used to evaluate the release properties of topical treatments (e.g., topical applications, gels, lotions, etc.).
The In Vitro Drug Release Testing market is evolving rapidly, driven by the growing emphasis on quality control, regulatory compliance, and the need for predictive drug performance data in pharmaceutical development. This testing plays a critical role in evaluating the release characteristics of drug formulations, providing essential insights into product behavior before clinical use. As the pharmaceutical industry expands its focus on complex generics, novel drug delivery systems, and biosimilars, demand for precise and reproducible in vitro testing methods continues to rise. Technological advancements in dissolution testing equipment, automation, and analytical techniques are enhancing the accuracy and efficiency of testing processes. Additionally, regulatory bodies are placing increased importance on in vitro release data, reinforcing its role in supporting formulation optimization and ensuring consistent therapeutic outcomes.
This report delivers a comprehensive overview of the global In Vitro Drug Release Testing market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding In Vitro Drug Release Testing. The In Vitro Drug Release Testing market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global In Vitro Drug Release Testing market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist In Vitro Drug Release Testing manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
QPS
Recipharm
CPL
MedPharm
Nuvisan
Diteba
Eurofins
Raptim Research
The J. Molner Company
Medicilon
Porton
Joanneum Research
Frontage
CD Formulation
Stira Pharmaceuticals
BioLInk LIfe Sciences
Sun-Novo
Segment by Type
Formulation Optimization
Quality Control
Generic Drug Approval
Others
Segment by Application
Creams
Ointments
Gels
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for In Vitro Drug Release Testing companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Drug Release Testing Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Formulation Optimization
1.2.3 Quality Control
1.2.4 Generic Drug Approval
1.2.5 Others
1.3 Market by Application
1.3.1 Global In Vitro Drug Release Testing Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Creams
1.3.3 Ointments
1.3.4 Gels
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Drug Release Testing Market Perspective (2021–2032)
2.2 Global In Vitro Drug Release Testing Growth Trends by Region
2.2.1 Global In Vitro Drug Release Testing Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 In Vitro Drug Release Testing Historic Market Size by Region (2021–2026)
2.2.3 In Vitro Drug Release Testing Forecasted Market Size by Region (2027–2032)
2.3 In Vitro Drug Release Testing Market Dynamics
2.3.1 In Vitro Drug Release Testing Industry Trends
2.3.2 In Vitro Drug Release Testing Market Drivers
2.3.3 In Vitro Drug Release Testing Market Challenges
2.3.4 In Vitro Drug Release Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Drug Release Testing Players by Revenue
3.1.1 Global Top In Vitro Drug Release Testing Players by Revenue (2021–2026)
3.1.2 Global In Vitro Drug Release Testing Revenue Market Share by Players (2021–2026)
3.2 Global Top In Vitro Drug Release Testing Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by In Vitro Drug Release Testing Revenue
3.4 Global In Vitro Drug Release Testing Market Concentration Ratio
3.4.1 Global In Vitro Drug Release Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Drug Release Testing Revenue in 2025
3.5 Global Key Players of In Vitro Drug Release Testing Head Offices and Areas Served
3.6 Global Key Players of In Vitro Drug Release Testing, Products and Applications
3.7 Global Key Players of In Vitro Drug Release Testing, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 In Vitro Drug Release Testing Breakdown Data by Type
4.1 Global In Vitro Drug Release Testing Historic Market Size by Type (2021–2026)
4.2 Global In Vitro Drug Release Testing Forecasted Market Size by Type (2027–2032)
5 In Vitro Drug Release Testing Breakdown Data by Application
5.1 Global In Vitro Drug Release Testing Historic Market Size by Application (2021–2026)
5.2 Global In Vitro Drug Release Testing Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America In Vitro Drug Release Testing Market Size (2021–2032)
6.2 North America In Vitro Drug Release Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America In Vitro Drug Release Testing Market Size by Country (2021–2026)
6.4 North America In Vitro Drug Release Testing Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Drug Release Testing Market Size (2021–2032)
7.2 Europe In Vitro Drug Release Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe In Vitro Drug Release Testing Market Size by Country (2021–2026)
7.4 Europe In Vitro Drug Release Testing Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Drug Release Testing Market Size (2021–2032)
8.2 Asia-Pacific In Vitro Drug Release Testing Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific In Vitro Drug Release Testing Market Size by Region (2021–2026)
8.4 Asia-Pacific In Vitro Drug Release Testing Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America In Vitro Drug Release Testing Market Size (2021–2032)
9.2 Latin America In Vitro Drug Release Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America In Vitro Drug Release Testing Market Size by Country (2021–2026)
9.4 Latin America In Vitro Drug Release Testing Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Drug Release Testing Market Size (2021–2032)
10.2 Middle East & Africa In Vitro Drug Release Testing Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa In Vitro Drug Release Testing Market Size by Country (2021–2026)
10.4 Middle East & Africa In Vitro Drug Release Testing Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QPS
11.1.1 QPS Company Details
11.1.2 QPS Business Overview
11.1.3 QPS In Vitro Drug Release Testing Introduction
11.1.4 QPS Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.1.5 QPS Recent Development
11.2 Recipharm
11.2.1 Recipharm Company Details
11.2.2 Recipharm Business Overview
11.2.3 Recipharm In Vitro Drug Release Testing Introduction
11.2.4 Recipharm Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.2.5 Recipharm Recent Development
11.3 CPL
11.3.1 CPL Company Details
11.3.2 CPL Business Overview
11.3.3 CPL In Vitro Drug Release Testing Introduction
11.3.4 CPL Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.3.5 CPL Recent Development
11.4 MedPharm
11.4.1 MedPharm Company Details
11.4.2 MedPharm Business Overview
11.4.3 MedPharm In Vitro Drug Release Testing Introduction
11.4.4 MedPharm Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.4.5 MedPharm Recent Development
11.5 Nuvisan
11.5.1 Nuvisan Company Details
11.5.2 Nuvisan Business Overview
11.5.3 Nuvisan In Vitro Drug Release Testing Introduction
11.5.4 Nuvisan Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.5.5 Nuvisan Recent Development
11.6 Diteba
11.6.1 Diteba Company Details
11.6.2 Diteba Business Overview
11.6.3 Diteba In Vitro Drug Release Testing Introduction
11.6.4 Diteba Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.6.5 Diteba Recent Development
11.7 Eurofins
11.7.1 Eurofins Company Details
11.7.2 Eurofins Business Overview
11.7.3 Eurofins In Vitro Drug Release Testing Introduction
11.7.4 Eurofins Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.7.5 Eurofins Recent Development
11.8 Raptim Research
11.8.1 Raptim Research Company Details
11.8.2 Raptim Research Business Overview
11.8.3 Raptim Research In Vitro Drug Release Testing Introduction
11.8.4 Raptim Research Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.8.5 Raptim Research Recent Development
11.9 The J. Molner Company
11.9.1 The J. Molner Company Company Details
11.9.2 The J. Molner Company Business Overview
11.9.3 The J. Molner Company In Vitro Drug Release Testing Introduction
11.9.4 The J. Molner Company Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.9.5 The J. Molner Company Recent Development
11.10 Medicilon
11.10.1 Medicilon Company Details
11.10.2 Medicilon Business Overview
11.10.3 Medicilon In Vitro Drug Release Testing Introduction
11.10.4 Medicilon Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.10.5 Medicilon Recent Development
11.11 Porton
11.11.1 Porton Company Details
11.11.2 Porton Business Overview
11.11.3 Porton In Vitro Drug Release Testing Introduction
11.11.4 Porton Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.11.5 Porton Recent Development
11.12 Joanneum Research
11.12.1 Joanneum Research Company Details
11.12.2 Joanneum Research Business Overview
11.12.3 Joanneum Research In Vitro Drug Release Testing Introduction
11.12.4 Joanneum Research Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.12.5 Joanneum Research Recent Development
11.13 Frontage
11.13.1 Frontage Company Details
11.13.2 Frontage Business Overview
11.13.3 Frontage In Vitro Drug Release Testing Introduction
11.13.4 Frontage Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.13.5 Frontage Recent Development
11.14 CD Formulation
11.14.1 CD Formulation Company Details
11.14.2 CD Formulation Business Overview
11.14.3 CD Formulation In Vitro Drug Release Testing Introduction
11.14.4 CD Formulation Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.14.5 CD Formulation Recent Development
11.15 Stira Pharmaceuticals
11.15.1 Stira Pharmaceuticals Company Details
11.15.2 Stira Pharmaceuticals Business Overview
11.15.3 Stira Pharmaceuticals In Vitro Drug Release Testing Introduction
11.15.4 Stira Pharmaceuticals Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.15.5 Stira Pharmaceuticals Recent Development
11.16 BioLInk LIfe Sciences
11.16.1 BioLInk LIfe Sciences Company Details
11.16.2 BioLInk LIfe Sciences Business Overview
11.16.3 BioLInk LIfe Sciences In Vitro Drug Release Testing Introduction
11.16.4 BioLInk LIfe Sciences Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.16.5 BioLInk LIfe Sciences Recent Development
11.17 Sun-Novo
11.17.1 Sun-Novo Company Details
11.17.2 Sun-Novo Business Overview
11.17.3 Sun-Novo In Vitro Drug Release Testing Introduction
11.17.4 Sun-Novo Revenue in In Vitro Drug Release Testing Business (2021–2026)
11.17.5 Sun-Novo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In Vitro Drug Release Testing Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Formulation Optimization
Table 3. Key Players of Quality Control
Table 4. Key Players of Generic Drug Approval
Table 5. Key Players of Others
Table 6. Global In Vitro Drug Release Testing Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global In Vitro Drug Release Testing Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global In Vitro Drug Release Testing Market Size by Region (US$ Million), 2021–2026
Table 9. Global In Vitro Drug Release Testing Market Share by Region (2021–2026)
Table 10. Global In Vitro Drug Release Testing Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global In Vitro Drug Release Testing Market Share by Region (2027–2032)
Table 12. In Vitro Drug Release Testing Market Trends
Table 13. In Vitro Drug Release Testing Market Drivers
Table 14. In Vitro Drug Release Testing Market Challenges
Table 15. In Vitro Drug Release Testing Market Restraints
Table 16. Global In Vitro Drug Release Testing Revenue by Players (US$ Million), 2021–2026
Table 17. Global In Vitro Drug Release Testing Market Share by Players (2021–2026)
Table 18. Global Top In Vitro Drug Release Testing Players by Tier (Tier 1, Tier 2, and Tier 3), based on In Vitro Drug Release Testing Revenue, 2025
Table 19. Ranking of Global Top In Vitro Drug Release Testing Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by In Vitro Drug Release Testing Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of In Vitro Drug Release Testing, Headquarters and Area Served
Table 22. Global Key Players of In Vitro Drug Release Testing, Products and Applications
Table 23. Global Key Players of In Vitro Drug Release Testing, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global In Vitro Drug Release Testing Market Size by Type (US$ Million), 2021–2026
Table 26. Global In Vitro Drug Release Testing Revenue Market Share by Type (2021–2026)
Table 27. Global In Vitro Drug Release Testing Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global In Vitro Drug Release Testing Revenue Market Share by Type (2027–2032)
Table 29. Global In Vitro Drug Release Testing Market Size by Application (US$ Million), 2021–2026
Table 30. Global In Vitro Drug Release Testing Revenue Market Share by Application (2021–2026)
Table 31. Global In Vitro Drug Release Testing Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global In Vitro Drug Release Testing Revenue Market Share by Application (2027–2032)
Table 33. North America In Vitro Drug Release Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America In Vitro Drug Release Testing Market Size by Country (US$ Million), 2021–2026
Table 35. North America In Vitro Drug Release Testing Market Size by Country (US$ Million), 2027–2032
Table 36. Europe In Vitro Drug Release Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe In Vitro Drug Release Testing Market Size by Country (US$ Million), 2021–2026
Table 38. Europe In Vitro Drug Release Testing Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific In Vitro Drug Release Testing Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific In Vitro Drug Release Testing Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific In Vitro Drug Release Testing Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America In Vitro Drug Release Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America In Vitro Drug Release Testing Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America In Vitro Drug Release Testing Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa In Vitro Drug Release Testing Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa In Vitro Drug Release Testing Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa In Vitro Drug Release Testing Market Size by Country (US$ Million), 2027–2032
Table 48. QPS Company Details
Table 49. QPS Business Overview
Table 50. QPS In Vitro Drug Release Testing Product
Table 51. QPS Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 52. QPS Recent Development
Table 53. Recipharm Company Details
Table 54. Recipharm Business Overview
Table 55. Recipharm In Vitro Drug Release Testing Product
Table 56. Recipharm Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 57. Recipharm Recent Development
Table 58. CPL Company Details
Table 59. CPL Business Overview
Table 60. CPL In Vitro Drug Release Testing Product
Table 61. CPL Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 62. CPL Recent Development
Table 63. MedPharm Company Details
Table 64. MedPharm Business Overview
Table 65. MedPharm In Vitro Drug Release Testing Product
Table 66. MedPharm Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 67. MedPharm Recent Development
Table 68. Nuvisan Company Details
Table 69. Nuvisan Business Overview
Table 70. Nuvisan In Vitro Drug Release Testing Product
Table 71. Nuvisan Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 72. Nuvisan Recent Development
Table 73. Diteba Company Details
Table 74. Diteba Business Overview
Table 75. Diteba In Vitro Drug Release Testing Product
Table 76. Diteba Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 77. Diteba Recent Development
Table 78. Eurofins Company Details
Table 79. Eurofins Business Overview
Table 80. Eurofins In Vitro Drug Release Testing Product
Table 81. Eurofins Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 82. Eurofins Recent Development
Table 83. Raptim Research Company Details
Table 84. Raptim Research Business Overview
Table 85. Raptim Research In Vitro Drug Release Testing Product
Table 86. Raptim Research Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 87. Raptim Research Recent Development
Table 88. The J. Molner Company Company Details
Table 89. The J. Molner Company Business Overview
Table 90. The J. Molner Company In Vitro Drug Release Testing Product
Table 91. The J. Molner Company Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 92. The J. Molner Company Recent Development
Table 93. Medicilon Company Details
Table 94. Medicilon Business Overview
Table 95. Medicilon In Vitro Drug Release Testing Product
Table 96. Medicilon Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 97. Medicilon Recent Development
Table 98. Porton Company Details
Table 99. Porton Business Overview
Table 100. Porton In Vitro Drug Release Testing Product
Table 101. Porton Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 102. Porton Recent Development
Table 103. Joanneum Research Company Details
Table 104. Joanneum Research Business Overview
Table 105. Joanneum Research In Vitro Drug Release Testing Product
Table 106. Joanneum Research Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 107. Joanneum Research Recent Development
Table 108. Frontage Company Details
Table 109. Frontage Business Overview
Table 110. Frontage In Vitro Drug Release Testing Product
Table 111. Frontage Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 112. Frontage Recent Development
Table 113. CD Formulation Company Details
Table 114. CD Formulation Business Overview
Table 115. CD Formulation In Vitro Drug Release Testing Product
Table 116. CD Formulation Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 117. CD Formulation Recent Development
Table 118. Stira Pharmaceuticals Company Details
Table 119. Stira Pharmaceuticals Business Overview
Table 120. Stira Pharmaceuticals In Vitro Drug Release Testing Product
Table 121. Stira Pharmaceuticals Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 122. Stira Pharmaceuticals Recent Development
Table 123. BioLInk LIfe Sciences Company Details
Table 124. BioLInk LIfe Sciences Business Overview
Table 125. BioLInk LIfe Sciences In Vitro Drug Release Testing Product
Table 126. BioLInk LIfe Sciences Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 127. BioLInk LIfe Sciences Recent Development
Table 128. Sun-Novo Company Details
Table 129. Sun-Novo Business Overview
Table 130. Sun-Novo In Vitro Drug Release Testing Product
Table 131. Sun-Novo Revenue in In Vitro Drug Release Testing Business (US$ Million), 2021–2026
Table 132. Sun-Novo Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. In Vitro Drug Release Testing Picture
Figure 2. Global In Vitro Drug Release Testing Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global In Vitro Drug Release Testing Market Share by Type: 2025 vs 2032
Figure 4. Formulation Optimization Features
Figure 5. Quality Control Features
Figure 6. Generic Drug Approval Features
Figure 7. Others Features
Figure 8. Global In Vitro Drug Release Testing Market Size by Application (US$ Million), 2021–2032
Figure 9. Global In Vitro Drug Release Testing Market Share by Application: 2025 vs 2032
Figure 10. Creams Case Studies
Figure 11. Ointments Case Studies
Figure 12. Gels Case Studies
Figure 13. Others Case Studies
Figure 14. In Vitro Drug Release Testing Report Years Considered
Figure 15. Global In Vitro Drug Release Testing Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global In Vitro Drug Release Testing Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global In Vitro Drug Release Testing Market Share by Region: 2025 vs 2032
Figure 18. Global In Vitro Drug Release Testing Market Share by Players in 2025
Figure 19. Global In Vitro Drug Release Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by In Vitro Drug Release Testing Revenue in 2025
Figure 21. North America In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America In Vitro Drug Release Testing Market Share by Country (2021–2032)
Figure 23. United States In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe In Vitro Drug Release Testing Market Share by Country (2021–2032)
Figure 27. Germany In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific In Vitro Drug Release Testing Market Share by Region (2021–2032)
Figure 35. China In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America In Vitro Drug Release Testing Market Share by Country (2021–2032)
Figure 43. Mexico In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa In Vitro Drug Release Testing Market Share by Country (2021–2032)
Figure 47. Israel In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE In Vitro Drug Release Testing Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. QPS Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 51. Recipharm Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 52. CPL Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 53. MedPharm Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 54. Nuvisan Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 55. Diteba Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 56. Eurofins Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 57. Raptim Research Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 58. The J. Molner Company Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 59. Medicilon Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 60. Porton Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 61. Joanneum Research Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 62. Frontage Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 63. CD Formulation Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 64. Stira Pharmaceuticals Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 65. BioLInk LIfe Sciences Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 66. Sun-Novo Revenue Growth Rate in In Vitro Drug Release Testing Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
